N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Neurocircuitry of Addiction

Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340 · see citing works

The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid

Aruoma, O. I., Halliwell, B. B., Hoey, B. M., & Butler, J. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90066-x · Cited by 1,774 · see citing works

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · see citing works

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.

Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., & Carlsson, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.237 · Cited by 742 · see citing works

Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse

Baker, D. L., McFarland, K., LAKE, R. W., Shen, H., Tang, X., Toda, S., & Kalivas, P. W. (2003) · Nature Neuroscience · doi:10.1038/nn1069 · Cited by 740 · see citing works

Glutathione Pathways in the Brain

Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597 · see citing works

The Origin and Neuronal Function ofIn VivoNonsynaptic Glutamate

Baker, D. L., Xi, Z., Shen, H., Swanson, C. J., & Kalivas, P. W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09134.2002 · Cited by 584 · see citing works

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · see citing works

Oxidative stress markers in bipolar disorder: A meta-analysis

Andreazza, A. C., Kauer-Sant'Anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.013 · Cited by 526 · see citing works

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500 · see citing works

The antioxidants α‐lipoic acid and <i>N</i> ‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice

Farr, S. A., Poon, H. F., Dogrukol‐Ak, D., Drake, J., Banks, W. A., Eyerman, E., Butterfield, D. A., & Morley, J. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01580.x · Cited by 459 · see citing works

N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania: A Double-blind, Placebo-Controlled Study

Grant, J. E., Odlaug, B. L., & Won Kim, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.60 · Cited by 424 · cited 8× · see citing works

Glutathione, ascorbate, and cellular protection.

Meister, A. (1994) · PubMed · Cited by 421 · see citing works

<i>N</i> -acetylcysteine for antioxidant therapy: pharmacology and clinical utility

Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14728220802517901 · Cited by 413 · see citing works

Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking

Moran, M., McFarland, K., Meléndez, R. I., Kalivas, P. W., & Seamans, J. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1007-05.2005 · Cited by 412 · see citing works

N-Acetylcysteine reverses cocaine-induced metaplasticity

Moussawi, K., Pacchioni, A. M., Moran, M., Olive, M. F., Gass, J. T., Lavı́n, A., & Kalivas, P. W. (2009) · Nature Neuroscience · doi:10.1038/nn.2250 · Cited by 400 · see citing works

Glutamate transmission in addiction

Kalivas, P. W., LaLumiere, R. T., Knackstedt, L. A., & Shen, H. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.011 · Cited by 389 · see citing works

Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients

Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371 · see citing works

Clinical Pharmacokinetics of N-Acetylcysteine

Holdiness, M. R. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199120020-00004 · Cited by 359 · see citing works

Meta-analysis of the dose-response relationship of SSRI in obsessive–compulsive disorder

Bloch, M. H., McGuire, J., Landeros-Weisenberger, A., Leckman, J. F., & Pittenger, C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.50 · Cited by 317 · see citing works

N-Acetyl Cysteine, a Glutamate-Modulating Agent, in the Treatment of Pathological Gambling: A Pilot Study

Grant, J. E., Kim, S. W., & Odlaug, B. L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.021 · Cited by 302 · see citing works

The systemic availability of oral glutathione

Witschi, A. T., Reddy, S. K., Stofer, B., & Lauterburg, B. H. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02284971 · Cited by 274 · see citing works

Epidemiologic and clinical updates on impulse control disorders: a critical review

Dell’Osso, B., Altamura, A. C., Allen, A., Marazziti, D., & Hollander, E. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0668-0 · Cited by 272 · see citing works

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.

Drexhage, R. C., Knijff, E. M., Padmos, R. C., Heul-Nieuwenhuijzen, L. V. D., Beumer, W., Versnel, M. A., & Drexhage, H. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.144 · Cited by 263 · see citing works

The Role of Cystine-Glutamate Exchange in Nicotine Dependence in Rats and Humans

Knackstedt, L. A., LaRowe, S., Mardikian, P., Malcolm, R., Upadhyaya, H., Hedden, S., Markou, A., & Kalivas, P. W. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.040 · Cited by 260 · see citing works

Administration of N‐acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke

Khan, M., Sekhon, B., Jatana, M., Giri, S., Gilg, A. G., Sekhon, C., Singh, I., & Singh, A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20087 · Cited by 245 · see citing works

Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs

Cunha‐Oliveira, T., Rego, A. C., & Oliveira, C. R. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.03.002 · Cited by 243 · see citing works

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

Kunz, M., Gama, C. S., Andreazza, A. C., Salvador, M. M., Ceresér, K. M., Gomes, F. A., Belmonte-de-Abreu, P. S., Berk, M., & Kapczinski, F. P. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.001 · Cited by 241 · see citing works

Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease

Adair, J. C., Knoefel, J. E., & Morgan, N. (2001) · Neurology · doi:10.1212/wnl.57.8.1515 · Cited by 240 · see citing works

Expression of brain‐derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs

Bai, O., Chlan‐Fourney, J., Bowen, R., Keegan, D. A., & Li, X. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10440 · Cited by 239 · see citing works

Repeated<i>N</i>-Acetylcysteine Administration Alters Plasticity-Dependent Effects of Cocaine

Madayag, A., Lobner, D., Kau, K. S., Mantsch, J. R., Abdulhameed, O., Hearing, M., Grier, M. D., & Baker, D. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2808-07.2007 · Cited by 225 · see citing works

Is Cocaine Desire Reduced by N -Acetylcysteine?

LaRowe, S. D., Myrick, H., Hedden, S. L., Mardikian, P. N., Saladin, M. E., McRae‐Clark, A. L., Brady, K. T., Kalivas, P. W., & Malcolm, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1115 · Cited by 210 · see citing works

Inflammatory markers in depression

Dinan, T. G. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328315a561 · Cited by 206 · see citing works

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

Lafleur, D. L., Pittenger, C., Kelmendi, B., Gardner, T., Wasylink, S., Malison, R. T., Sanacora, G., Krystal, J. H., & Coric, V. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0246-6 · Cited by 200 · see citing works

3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder

Andreazza, A. C., Kapczinski, F. P., Kauer‐Sant’Anna, M., Walz, J. C., Bond, D. J., Gonçalves, C. A., Young, L. T., & Yatham, L. N. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0935 · Cited by 199 · see citing works

The Neurochemical Circuitry of Schizophrenia

Carlsson, A. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-931483 · Cited by 199 · see citing works

Glutathione: a novel treatment target in psychiatry

Berk, M., Ng, F., Dean, O., Dodd, S., & Bush, A. I. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.001 · Cited by 183 · see citing works

Safety and Tolerability of N‐Acetylcysteine in Cocaine‐Dependent Individuals

LaRowe, S. D., Mardikian, P. N., Malcolm, R. J., Myrick, H., Kalivas, P. W., McFarland, K., Saladin, M. E., McRae‐Clark, A. L., & Brady, K. T. (2006) · American Journal on Addictions · doi:10.1080/10550490500419169 · Cited by 181 · see citing works

An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study

Mardikian, P. N., LaRowe, S. D., Hedden, S., Kalivas, P. W., & Malcolm, R. J. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.10.001 · Cited by 179 · see citing works

Antioxidant Enzyme Activities and Malondialdehyde Levels in Patients with Obsessive-Compulsive Disorder

Kuloğlu, M., Atmaca, M., Tezcan, E., Geçici, Ö., Tunckol, H., & Üstündağ, B. (2002) · Neuropsychobiology · doi:10.1159/000063573 · Cited by 178 · see citing works

Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients

Raffa, M., Mechri, A., Othman, L. B., Fendri, C., Gaha, L., & Kerkeni, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.018 · Cited by 173 · see citing works

Inhibitory Effect on Cerebral Inflammatory Response following Traumatic Brain Injury in Rats: A Potential Neuroprotective Mechanism of N‐Acetylcysteine

Chen, G., Shi, J., Hu, Z., & Hang, C. (2008) · Mediators of Inflammation · doi:10.1155/2008/716458 · Cited by 170 · see citing works

S-Nitrosothiols signal hypoxia-mimetic vascular pathology

Palmer, L. A., Doctor, A., Chhabra, P., Sheram, M. L., Laubach, V. E., Karlinsey, M. Z., Forbes, M. S., Macdonald, T. L., & Gaston, B. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29444 · Cited by 161 · see citing works

Maintenance of glutathione content is isolated hepatocyctes

Viña, J., Hems, R., & Krebs, H. A. (1978) · Biochemical Journal · doi:10.1042/bj1700627 · Cited by 160 · see citing works

The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-γ

Bian, Q., Kato, T. A., Monji, A., Hashioka, S., Mizoguchi, Y., Horikawa, H., & Kanba, S. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.06.031 · Cited by 155 · see citing works

Long-term antipsychotic treatments and crossover studies in rats: Differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain

Pillai, A., Parikh, V., Terry, A. V., & Mahadik, S. P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.011 · Cited by 153 · see citing works

A psychological and neuroanatomical model of obsessive-compulsive disorder

Huey, E. D., Zahn, R., Krueger, F., Moll, J., Kapogiannis, D., Wassermann, E. M., & Grafman, J. (2008) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2008.20.4.390 · Cited by 152 · see citing works

N‐Acetyl Cysteine‐Induced Blockade of Cocaine‐Induced Reinstatement

Baker, D. L., McFarland, K., LAKE, R. W., Shen, H., Toda, S., & Kalivas, P. W. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.023 · Cited by 148 · see citing works

Glutamatergic (N-Methyl-d-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?

Marek, G. J., Behl, B., Bespalov, A., Groß, G., Lee, Y., & Schoemaker, H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.059865 · Cited by 145 · see citing works

Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability

Carter, C. J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.023 · Cited by 126 · see citing works

Late <i>N</i>‐acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation

Lanté, F., Meunier, J., Guiramand, J., De Jesus Ferreira, M., Cambonie, G., Aimar, R., Cohen‐Solal, C., Maurice, T., Vignes, M., & Barbanel, G. (2008) · Hippocampus · doi:10.1002/hipo.20421 · Cited by 124 · see citing works

On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder

Carlsson, M. L. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00146-9 · Cited by 121 · see citing works

Blunted cystine–glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking

Kau, K. S., Madayag, A., Mantsch, J. R., Grier, M. D., Abdulhameed, O., & Baker, D. L. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.010 · Cited by 113 · see citing works

Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.

van Schooten, F., Nia, A. B., Nia, A. B., Flora, S. D., D’Agostini, F., Izzotti, A., Camoirano, A., Balm, A. J. M., Dallinga, J. W., Bast, A., et al. (2002) · PubMed · Cited by 111 · see citing works

Effect of Oral N-Acetylcysteine Treatment on Plasma Inflammatory and Oxidative Stress Markers in Peritoneal Dialysis Patients: A Placebo-Controlled Study

do Nascimento, M. M., Suliman, M. E., Silva, M., Chinaglia, T., Marchioro, J. C., Hayashi, S. Y., RIELLA, M. C., Lindholm, B., & Anderstam, B. (2010) · Peritoneal Dialysis International · doi:10.3747/pdi.2009.00073 · Cited by 111 · see citing works

<i>N</i>‐Acetylcysteine (NAC) in Young Marijuana Users: An Open‐Label Pilot Study

Gray, K. M., Watson, N. L., Carpenter, M. J., & LaRowe, S. D. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00027.x · Cited by 109 · see citing works

Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder

Özdemir, E., Çetinkaya, S., Erşan, S., Kucukosman, S., & Erşan, E. E. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.004 · Cited by 108 · see citing works

Metabolism of N-acetyl-l-cysteine Some structural requirements for the deacetylation and consequences for the oral bioavailability

Sjödin, K., Nilsson, E., Hallberg, A., & Tunek, A. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90677-1 · Cited by 106 · see citing works

Modulation of glutamate receptor functions by glutathione

Oja, S. S. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00031-0 · Cited by 105 · see citing works

A Role for Glutathione in the Pathophysiology of Bipolar Disorder and Schizophrenia? Animal Models and Relevance to Clinical Practice

Dean, O. M., van den Buuse, M., Bush, A. I., Copolov, D., Ng, F., Dodd, S., & Berk, M. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803060 · Cited by 101 · see citing works

N-Acetyl Cysteine in the Treatment of Grooming Disorders

Odlaug, B. L., & Grant, J. E. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000264976.86990.00 · Cited by 94 · see citing works

Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive–compulsive disorder

Erşan, S., Bakır, S., Erşan, E. E., & Doğan, O. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.03.034 · Cited by 90 · see citing works

Oxidative imbalance in obsessive compulsive disorder patients: A total evaluation of oxidant–antioxidant status

Selek, S., Herken, H., Bulut, M., Ceylan, M. F., Çelık, H., SAVAS, H. A., & Erel, Ö. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.10.002 · Cited by 85 · see citing works

Glutathione-induced inhibition of Na+-independent and -dependent bindings of L-[3H] glutamate in rat brain

Ogita, K., Kitago, T., Nakamuta, H., Fukuda, Y., Koida, M., Ogawa, Y., & Yoneda, Y. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90482-0 · Cited by 82 · see citing works

Glutathione Is an Endogenous Ligand of Rat Brain N-Methyl-D-Aspartate (NMDA) and 2-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionate (AMPA) Receptors

Varga, V., Jenei, Z., Janáky, R., Saransaari, P., & Oja, S. S. (1997) · Neurochemical Research · doi:10.1023/a:1027377605054 · Cited by 81 · see citing works

Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive–compulsive disorder

Chakraborty, S., Singh, O. P., Dasgupta, A., Mandal, N., & Das, H. N. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.01.001 · Cited by 76 · see citing works

Addicted to Hair Pulling? How an Alternate Model of Trichotillomania May Improve Treatment Outcome

Grant, J., Odlaug, B., & Potenza, M. (2007) · Harvard Review of Psychiatry · doi:10.1080/10673220701298407 · Cited by 74 · see citing works

Beneficial effects of<i>N-</i>acetylcysteine in treatment resistant schizophrenia

Bulut, M., Savas, H. A., Altindag, A., Virit, O., & Dalkilic, A. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903144004 · Cited by 73 · see citing works

Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile

Pazvantoğlu, O., Selek, Ş., Okay, İ. T., Şengül, C., Karabekiroğlu, K., Dılbaz, N., & Erel, Ö. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02015.x · Cited by 69 · see citing works

Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.

Neuwelt, E. A., Pagel, M. A., Hasler, B. P., DeLoughery, T. G., & Muldoon, L. L. (2001) · PubMed · Cited by 65 · see citing works

Dose dependent pharmacokinetics of N‐ACETYLCYSTEINE AFTER ORAL DOSING TO MAN

Borgström, L., & Kågedal, B. (1990) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510110205 · Cited by 65 · see citing works

Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death

Bailey, B., Blais, R., & Letarte, A. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.05.014 · Cited by 64 · see citing works

Nail-Biting Stuff? The Effect of N-acetyl Cysteine on Nail-Biting

Berk, M., Jeavons, S., Dean, O. M., Dodd, S., Moss, K., Gama, C. S., & Malhi, G. S. (2009) · CNS Spectrums · doi:10.1017/s1092852900023002 · Cited by 58 · see citing works

The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice

Chen, H., Stoker, A. K., & Markou, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1802-2 · Cited by 45 · see citing works

Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons

Himi, T., Ikeda, M., Yasuhara, T., & Murota, S. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10510 · Cited by 43 · see citing works

Trichotillomania across the life span.

Kratochvil, C., & Bloch, M. (2009) · Journal of the American Academy of Child and Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ae09f3 · Cited by 42 · see citing works

The correlation between early alcohol withdrawal severity and oxidative stress in patients with alcohol dependence

Huang, M., Chen, C., Peng, F.-C., Tang, S.-H., & Chen, C.-H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.009 · Cited by 42 · see citing works

Modulation of peroxisome proliferator‐activated receptor‐α activity by N‐acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures

Paintlia, M. K., Paintlia, A. S., Khan, M., Singh, I., & Singh, A. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05199.x · Cited by 41 · see citing works

Modulation of [3H]Dopamine Release by Glutathione in Mouse Striatal Slices

Janáky, R., Dohovics, R., Saransaari, P., & Oja, S. S. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9315-z · Cited by 39 · see citing works

Prooxidative/antioxidative homeostasis in heroin addiction and detoxification

Pereska, Z., Dejanova, B., Bozinovska, C., et al. (2007) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656939 · Cited by 34 · see citing works

Qualitative Methods in Early-Phase Drug Trials

Berk, M., Munib, A., Dean, O. M., Malhi, G. S., Kohlmann, K., Schapkaitz, I., Jeavons, S., Katz, F., Anderson‐Hunt, M., Conus, P., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05741yel · Cited by 33 · see citing works

The effect of N‐acetylcysteine on amphetamine‐mediated dopamine release in rat brain striatal slices by ion‐pair reversed‐phase high performance liquid chromatography

Gere‐Pászti, E., & Jakus, J. (2009) · Biomedical Chromatography · doi:10.1002/bmc.1171 · Cited by 26 · see citing works

Acetaminophen Poisoning: A Case Report of the use of Acetylcysteine

Scalley, R. D., & Conner, C. S. (1978) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/35.8.964 · Cited by 25 · see citing works

Effects of N‐Acetyl‐l‐Cysteine on the Reduction of Brain Dopamine Transporters in Monkey Treated with Methamphetamine

Hashimoto, K., Tsukada, H., Nishiyama, S., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.028 · Cited by 19 · see citing works

Facilitation Action of N‐Acetylcysteine on the Anticonvulsant Effect of Sodium Valproate in Mice

Devi, P. U., Pillai, K. K., & Vohora, D. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_377.x · Cited by 11 · see citing works

The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review

Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.269 · Cited by 1,483 · see citing works

Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions

Lushchak, V. I. (2012) · Journal of Amino Acids · doi:10.1155/2012/736837 · Cited by 1,266 · see citing works

N-Acetylcysteine (NAC): Impacts on Human Health

Tenório, M. C. D. S., Graciliano, N. G., Moura, F. A., Oliveira, A. C. M. D., & Goulart, M. O. F. (2021) · Antioxidants · doi:10.3390/antiox10060967 · Cited by 526 · see citing works

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463 · see citing works

The promise of N-acetylcysteine in neuropsychiatry

Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434 · see citing works

Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment

Pittenger, C., Bloch, M. H., & Williams, K. (2011) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2011.09.006 · Cited by 426 · see citing works

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325 · see citing works

A Double-Blind Randomized Controlled Trial of <i>N</i> -Acetylcysteine in Cannabis-Dependent Adolescents

Gray, K. M., Carpenter, M. J., Baker, N. L., DeSantis, S. M., Kryway, E., Hartwell, K. J., McRae-Clark, A. L., & Brady, K. T. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010055 · Cited by 306 · see citing works

The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder

Wu, K., Hanna, G. L., Rosenberg, D. R., & Arnold, P. D. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.007 · Cited by 264 · see citing works

The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials

Firth, J., Teasdale, S. B., Allott, K., Siskind, D., Marx, W., Cotter, J., Veronese, N., Schuch, F., Smith, L., Solmi, M., et al. (2019) · World Psychiatry · doi:10.1002/wps.20672 · Cited by 214 · see citing works

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Slifstein, M., Javitt, D. C., Lieberman, J. A., Abi-Dargham, A., & Girgis, R. R. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.136 · Cited by 205 · see citing works

The Efficacy of Adjunctive<i>N</i>-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Dean, O. M., Cotton, S. M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., Schapkaitz, I., et al. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08454 · Cited by 172 · see citing works

Anti-inflammatory treatments for mood disorders: Systematic review and meta-analysis

Husain, M. I., Strawbridge, R., Stokes, P. R., & Young, A. H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725711 · Cited by 139 · see citing works

Minocycline: Therapeutic Potential in Psychiatry

Dean, O. M., Data-Franco, J., Giorlando, F., & Berk, M. (2012) · CNS Drugs · doi:10.2165/11632000-000000000-00000 · Cited by 131 · see citing works

Role of the Astroglial Glutamate Exchanger xCT in Ventral Hippocampus in Resilience to Stress

Nasca, C., Bigio, B., Zelli, D., de Angelis, P., Lau, T., Okamoto, M., Soya, H., Ni, J., Brichta, L., Greengard, P., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.020 · Cited by 113 · see citing works

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

Bradlow, R. C. J., Berk, M., Kalivas, P. W., Back, S. E., & Kanaan, R. A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00907-3 · Cited by 87 · see citing works

Glycine transport inhibitors in the treatment of schizophrenia

Javitt, D. C. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_12 · Cited by 83 · see citing works

<i>N</i>-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study

Prado, E., Maes, M., Piccoli, L. G., Baracat, M., Barbosa, D. S., Franco, O., Dodd, S., Berk, M., & Vargas Nunes, S. O. (2015) · Redox Report · doi:10.1179/1351000215y.0000000004 · Cited by 69 · see citing works

Effects of <scp>N</scp>‐acetyl cysteine on cognitive function in bipolar disorder

Dean, O. M., Bush, A. I., Copolov, D. L., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02392.x · Cited by 58 · see citing works

A preliminary investigation on the efficacy of <i>N</i> -acetyl cysteine for mania or hypomania

Vieira da Silva Magalhães, P., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Berk, M. (2013) · Australian &amp; New Zealand Journal of Psychiatry · doi:10.1177/0004867413481631 · Cited by 58 · see citing works

Trichotillomania (hair pulling disorder): Clinical characteristics, psychosocial aspects, treatment approaches, and ethical considerations

França, K., Kumar, A., Castillo, D., Jafferany, M., Hyczy da Costa Neto, M., Damevska, K., Wollina, U., & Lotti, T. (2019) · Dermatologic Therapy · doi:10.1111/dth.12622 · Cited by 51 · see citing works

Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis

Hadi, F., Kashefinejad, S., Kamalzadeh, L., Hoobehfekr, S., & Shalbafan, M. (2021) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-021-00534-6 · Cited by 36 · see citing works

Mitochondrial Dysfunction in Bipolar Disorder: Lessons from Brain Imaging and Molecular Markers

Minuzzi, L., Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2011) · Revista Colombiana de Psiquiatría · doi:10.1016/s0034-7450(14)60201-8 · Cited by 7 · see citing works

333: Direct Comparison of 20-Hour IV N-acetylcysteine, 36-Hour By Mouth N-acetylcysteine, and 72-Hour By Mouth N-acetylcysteine for Acute Acetaminophen Poisoning

Williamson, K., Mycyk, M. B., & Wahl, M. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.06.601

Glutamatergic lateral hypothalamus promotes defensive behaviors

Chen, L., Cai, P., Wang, R.-F., Lu, Y., Chen, H., Guo, Y.-R., Huang, S., Hu, L., Chen, J., Zheng, Z.-H., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108239 · Cited by 23 · see citing works

BET 1: In paracetamol overdose, is oral N-acetylcysteine as effective as intravenous N-acetylcysteine?

Woodhead, K., & Foex, B. A. (2018) · Emergency Medicine Journal · doi:10.1136/emermed-2018-208093.2 · Cited by 3 · see citing works

Functional implications of glutamatergic projections to the ventral tegmental area

Geisler, S., & Wise, R. A. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.4-5.227 · Cited by 125 · see citing works

Glutamatergic neurons in the paraventricular hypothalamic nucleus regulate isoflurane anesthesia in mice

Yin, J., Qin, J., Lin, Z.-J., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202200974rr · Cited by 15 · see citing works